Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pralatrexate in peripheral T-cell lymphoma
NCT01420679Phase 3Terminated
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- Aug 2011
- Primary completion
- Dec 2017
- Countries
- 13
01
Overview
A Phase 3 trial of pralatrexate in peripheral T-cell lymphoma (PTCL), sponsored by Spectrum Pharmaceuticals, Inc.. Started Aug 2011; status: terminated.
02
Drugs
pralatrexate
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01420679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01420679.